Literature DB >> 34710793

Human bone marrow-derived mesenchymal stem cells play a role as a vascular pericyte in the reconstruction of human BBB on the angiogenesis microfluidic chip.

Sumin Kim1, Somin Lee2, Jungeun Lim3, Hyeri Choi2, Habin Kang2, Noo Li Jeon4, Youngsook Son5.   

Abstract

A blood-brain barrier (BBB) on a chip similar to the in vivo BBB is important for evaluating the efficacy of reparative cell therapeutics for ischemic stroke in vitro. In this study, we established human BBB-like microvasculature on an angiogenesis microfluidic chip and analyzed the role of human pericytes (hPCs) and human astrocytes (hACs) on the architecture of human brain microvascular endothelial cells (hBMEC)-derived microvasculature on a chip. We found that human bone marrow mesenchymal stem cells (hBM-MSCs) play a role as perivascular pericytes in tight BBB reformation with a better vessel-constrictive capacity than that of hPCs, providing evidence of reparative stem cells on BBB repair rather than a paracrine effect. We also demonstrated that pericytes play an important role in vessel constriction, and astrocytes may induce the maturation of a capillary network. Higher expression of VEGF, SDF-1α, PDGFRβ, N-cadherin, and α-SMA in hBM-MSCs than in hPCs and their subsequent downregulation with hBMEC co-culture suggest that hBM-MSCs may be better recruited and engaged in the BBB-microvasculature than hPCs. Collectively, the human BBB on a chip may be adopted as an alternative to evaluate in vitro cellular behavior and the engagement of cell therapeutics in BBB regeneration and may also be used for studying stroke.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BBB-On-a-chip; BM-MSC; Blood-brain barrier; Microfluidic chip; Pericyte

Mesh:

Year:  2021        PMID: 34710793     DOI: 10.1016/j.biomaterials.2021.121210

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  3 in total

Review 1.  Targetability of the neurovascular unit in inflammatory diseases of the central nervous system.

Authors:  Brandon C Smith; Rachel A Tinkey; Benjamin C Shaw; Jessica L Williams
Journal:  Immunol Rev       Date:  2022-07-31       Impact factor: 10.983

2.  Substance P Reduces Infarct Size and Mortality After Ischemic Stroke, Possibly Through the M2 Polarization of Microglia/Macrophages and Neuroprotection in the Ischemic Rat Brain.

Authors:  Woosung Ahn; Guangfan Chi; Sumin Kim; Youngsook Son; Mingzi Zhang
Journal:  Cell Mol Neurobiol       Date:  2022-09-16       Impact factor: 4.231

Review 3.  Engineering Organ-on-a-Chip to Accelerate Translational Research.

Authors:  Jihoon Ko; Dohyun Park; Somin Lee; Burcu Gumuscu; Noo Li Jeon
Journal:  Micromachines (Basel)       Date:  2022-07-28       Impact factor: 3.523

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.